Navigation Links
Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat

WATERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2007 - Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the results of a new study indicating that HIV resistant to Protease Inhibitors (PI) may have reduced potential for the development of resistance to the HIV maturation inhibitor bevirimat in laboratory assays. The study, carried out by scientists in Dr. Eric Freed's group at the HIV Drug Resistance Program at the National Cancer Institute, Frederick, MD, in collaboration with Panacos, was presented at the Cold Spring Harbor Laboratory's (CSHL) Retrovirus Conference held May 22-27, 2007 in Cold Spring Harbor, NY.

While resistance to bevirimat has not yet been reported in clinical studies, bevirimat-resistant HIV can be generated in the laboratory, as is the case with other HIV drugs. In previous studies where HIV was grown for several weeks in cell culture in the presence of bevirimat at suboptimal concentrations, mutations conferring resistance to bevirimat were found exclusively at or near bevirimat's target, the capsid-SP1 cleavage site in the HIV Gag protein. Cleavage of capsid from SP1, the final step in viral maturation, is mediated by the viral protease enzyme. Bevirimat inhibits this cleavage step by interacting with the capsid-SP1 junction in Gag, suggesting that pre-existing PI resistance mutations may have an impact on the development of bevirimat resistance.

In the new study, wild-type HIV, as well as HIV bearing major mutations conferring PI resistance, were grown in cell culture in the presence of bevirimat at suboptimal concentrations. Bevirimat resistance developed after several weeks in both wild-type and PI-resistant HIV, but took more than twice as long to develop in the PI-resistant virus. The bevirimat resistance mutation that appeared in PI-resistant virus was located at th
'"/>




Page: 1 2 3

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
8. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
11. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
Post Your Comments:
(Date:3/26/2015)... , March 26, 2015  The new Phonak CROS ... the unaidable ear to a Venture hearing aid worn on ... to hear speech from the side they could not hear ... is as easy and intuitive as a normal binaural fit, ... solution during the fitting session.    "Fitting single-sided ...
(Date:3/26/2015)... InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading ... healthcare industry in the United States ... secured a new $45.0 million credit facility with JPMorgan Chase ... facility with its prior lender group.  Effective ... senior secured credit agreement comprised of a $10.0 million asset-based ...
(Date:3/26/2015)... March 26, 2015 DePuy Synthes Companies ... Radlink, Inc., an emerging global leader in advanced ... with its hip replacement systems. The agreement further ... improve patient outcomes, increase patient satisfaction and reduce ... 81st annual meeting of the American Academy of ...
Breaking Medicine Technology:Phonak CROS II: The smart solution for single-sided deafness 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 2DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 3
... YORK, May 25, 2012  Delcath Systems, Inc. (NASDAQ: ... public offering of 13,333,340 shares of its common stock and ... at a combined price to the public of $1.50 per ... The warrants are exercisable at an exercise price of $1.65 ...
... and SÃO JERÔNIMO, Brazil, May 25, 2012 ... Limited (Osaka, Japan, "Takeda") and Multilab Indústria e ... Sul, Brazil, "Multilab") today jointly announced that both ... Brasil Ltda. (São Paulo, Brazil, "Takeda Brazil"), a ...
Cached Medicine Technology:Delcath Prices $20 Million Public Offering of Common Stock and Warrants 2Delcath Prices $20 Million Public Offering of Common Stock and Warrants 3Delcath Prices $20 Million Public Offering of Common Stock and Warrants 4Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 2Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 3Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 4
(Date:3/27/2015)... March 27, 2015 In light of ... number 1:15-cv-10429, U.S. District Court, District of Massachusetts; and ... Eastern District of Pennsylvania), the San Diego personal injury ... A.P.C. are announcing that they are available to investigate ... women who were prescribed Zofran while pregnant and who ...
(Date:3/26/2015)... Dallas, TX (PRWEB) March 26, 2015 ... of the 32nd annual Dallas Rhinoplasty Symposium and ... the years, reiterated the importance of evidence based medicine ... utilizing evidence from well conducted research. , "We often ... approaches to rhinoplasty, and while we are certainly not ...
(Date:3/26/2015)... Florida Hospital teamed up with ABC Action News to ... live Dr. Oz event, which took place at the Westfield ... thousand people came out to see Dr. Mehmet Oz and ... renowned cardiothoracic surgeon and Emmy award winning talk show host ... of experts for the live health expo. Florida Hospital physicians, ...
(Date:3/26/2015)... Old Tappan, NJ (PRWEB) March 26, 2015 ... research and statistical consulting firm, announced the release of ... by health experts to increase access to public restrooms ... recent trends in bathroom apps, BathroomMap does not facilitate ... a proprietary algorithm to identify and rate local establishments ...
(Date:3/26/2015)... 26, 2015 Dr. Alex Rabinovich and ... announce expanded offerings for Bay Area patients considering dental ... Center has long been a top-rated center, serving primarily ... to meet the strong demand by others throughout Northern ... a top-rated dental implant facility in San Francisco,”explained Dr. ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3
... By Alan Mozes HealthDay Reporter , THURSDAY, March ... your computer hour after hour may well have its benefits, ... dry, tired eyes, blurred vision, fatigue and headaches. This ... eye experts don,t agree on whether it,s serious or even ...
... Sevan Goenezen holds the promise of becoming a powerful ... complex computational research has led to a fast, inexpensive ... differentiate between benign and malignant tumors with a high ... Department of Mechanical, Aerospace, and Nuclear Engineering at Rensselaer, ...
... March 3, 2011 Men living in low-income neighbourhoods consume ... compared to women in these neighbourhoods, according to a study ... findings, published in the Journal of Epidemiology and Community ... when it comes to alcohol consumption. Heavy drinking is associated ...
... March 3, 2010 Elsevier / Gold Standard, a ... announced today several enhancements to its pricing tool, ProspectoRx, ... to facilitate pricing analysis. The rate and ... environment make current, accurate and easily accessible pricing information ...
... By Serena Gordon HealthDay Reporter , WEDNESDAY, March ... people with both type 2 diabetes and heart disease -- ... maintain the blood sugar levels typical of people without diabetes ... 2 diabetes and heart disease by 19 percent, according to ...
... March 3, 2011 Patients with end-stage renal disease who ... infection than those who undergo hemodialysis, a retrospective study at ... is less costly, easier on the body and provides greater ... "Patients actually survive better on peritoneal dialysis, have a ...
Cached Medicine News:Health News:Computer Vision Syndrome: Fact or Fiction? 2Health News:Computer Vision Syndrome: Fact or Fiction? 3Health News:Student innovation at Rensselaer Polytechnic Institute could lead to better breast cancer screening 2Health News:Student innovation at Rensselaer Polytechnic Institute could lead to better breast cancer screening 3Health News:Men in low income neighborhoods drink more than women: Study 2Health News:Tight Blood Sugar Control May Put Some Diabetics at Risk 2Health News:Tight Blood Sugar Control May Put Some Diabetics at Risk 3Health News:Portable, less costly peritoneal dialysis shows no additional catheter risk factors 2
... III Model 8042 increases therapy versatility ... to optimize sensing, pacing and cardiac ... offers unmatched insight through key heart ... efficiently track a patient's clinical status. ...
... The OTI-Scan 3D is ... ultrasound system available today. ... B and A-scan system ... Macintosh desktop or laptop ...
... is an extremely accurate digital A-scan system. ... noise probe and fast precise algorithm enables ... probe along the visual axis. The A5500 ... CRT monitor, built-in thermal printer, 5 different ...
... advanced IOL workstation. Accurate, efficient and easy ... used with a variety of regressive, theoretical, ... the needs of the patient. Convenient design ... foot pedal for hands-free operation, audible tone ...
Medicine Products: